Skip to content

Clinical trials

Phase 3 Macular Degeneration trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 3 Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20072
20083
20132
20141
20153
20181
20191
20203
20212
20222
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Unknown status3
Active, not recruiting2
Recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Bayer2
Ophthotech Corporation2
4D Molecular Therapeutics1
AbbVie1
Allergan1
Amgen1
Astellas Pharma Global Development, Inc.1
Bioeq GmbH1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration25
Choroidal Neovascularization6
Geographic Atrophy5
Wet Macular Degeneration5
Eye Diseases4
Retinal Diseases4
Vision Disorders4
Retinal Degeneration3
Blindness1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.